vs
Certara, Inc.(CERT)与Ecovyst Inc.(ECVT)财务数据对比。点击上方公司名可切换其他公司
Ecovyst Inc.的季度营收约是Certara, Inc.的1.9倍($199.4M vs $103.6M),Ecovyst Inc.同比增速更快(34.0% vs 3.3%),Certara, Inc.自由现金流更多($27.8M vs $22.9M),过去两年Ecovyst Inc.的营收复合增速更高(18.7% vs 3.6%)
Certara是全球领先的生物制药软件及咨询服务提供商,专注于建模模拟、监管科学领域的解决方案,服务药企、生物技术企业及医疗相关方,覆盖药物研发全周期,助力加快新疗法上市,降低研发风险与综合成本。
Ecovyst Inc.是一家全球可持续特种材料供应商,主营高性能催化剂与功能性添加剂的研发、生产,产品服务覆盖工业制造、消费品、环保等核心领域,助力全球客户提升运营效率、降低碳排放。
CERT vs ECVT — 直观对比
营收规模更大
ECVT
是对方的1.9倍
$103.6M
营收增速更快
ECVT
高出30.7%
3.3%
自由现金流更多
CERT
多$4.9M
$22.9M
两年增速更快
ECVT
近两年复合增速
3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $103.6M | $199.4M |
| 净利润 | $-5.9M | — |
| 毛利率 | — | 23.4% |
| 营业利润率 | 0.8% | 10.9% |
| 净利率 | -5.7% | — |
| 营收同比 | 3.3% | 34.0% |
| 净利润同比 | -189.6% | — |
| 每股收益(稀释后) | $-0.04 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CERT
ECVT
| Q4 25 | $103.6M | $199.4M | ||
| Q3 25 | $104.6M | $204.9M | ||
| Q2 25 | $104.6M | $176.1M | ||
| Q1 25 | $106.0M | $143.1M | ||
| Q4 24 | $100.4M | $148.9M | ||
| Q3 24 | $94.8M | $153.9M | ||
| Q2 24 | $93.3M | $154.0M | ||
| Q1 24 | $96.7M | $141.6M |
净利润
CERT
ECVT
| Q4 25 | $-5.9M | — | ||
| Q3 25 | $1.5M | $-79.3M | ||
| Q2 25 | $-2.0M | $6.0M | ||
| Q1 25 | $4.7M | $-3.6M | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $-1.4M | $14.3M | ||
| Q2 24 | $-12.6M | $8.3M | ||
| Q1 24 | $-4.7M | $1.2M |
毛利率
CERT
ECVT
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 25.4% | ||
| Q2 25 | — | 22.8% | ||
| Q1 25 | — | 13.3% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 29.3% | ||
| Q2 24 | — | 27.3% | ||
| Q1 24 | — | 23.5% |
营业利润率
CERT
ECVT
| Q4 25 | 0.8% | 10.9% | ||
| Q3 25 | 2.9% | 13.8% | ||
| Q2 25 | 9.1% | 9.0% | ||
| Q1 25 | 7.2% | -0.7% | ||
| Q4 24 | 6.0% | 15.1% | ||
| Q3 24 | 2.7% | 17.9% | ||
| Q2 24 | -9.7% | 14.1% | ||
| Q1 24 | -1.3% | 9.5% |
净利率
CERT
ECVT
| Q4 25 | -5.7% | — | ||
| Q3 25 | 1.5% | -38.7% | ||
| Q2 25 | -1.9% | 3.4% | ||
| Q1 25 | 4.5% | -2.5% | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | -1.4% | 9.3% | ||
| Q2 24 | -13.5% | 5.4% | ||
| Q1 24 | -4.8% | 0.9% |
每股收益(稀释后)
CERT
ECVT
| Q4 25 | $-0.04 | $0.06 | ||
| Q3 25 | $0.01 | $-0.69 | ||
| Q2 25 | $-0.01 | $0.05 | ||
| Q1 25 | $0.03 | $-0.03 | ||
| Q4 24 | $0.04 | $-0.26 | ||
| Q3 24 | $-0.01 | $0.12 | ||
| Q2 24 | $-0.08 | $0.07 | ||
| Q1 24 | $-0.03 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $189.4M | $197.2M |
| 总债务越低越好 | $293.1M | $392.6M |
| 股东权益账面价值 | $1.1B | $603.4M |
| 总资产 | $1.6B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.65× |
8季度趋势,按日历期对齐
现金及短期投资
CERT
ECVT
| Q4 25 | $189.4M | $197.2M | ||
| Q3 25 | $172.7M | $82.0M | ||
| Q2 25 | $162.3M | $69.6M | ||
| Q1 25 | $179.1M | $127.5M | ||
| Q4 24 | $179.2M | $131.4M | ||
| Q3 24 | $233.0M | $123.5M | ||
| Q2 24 | $224.6M | $83.3M | ||
| Q1 24 | $224.8M | $103.1M |
总债务
CERT
ECVT
| Q4 25 | $293.1M | $392.6M | ||
| Q3 25 | $293.5M | $854.8M | ||
| Q2 25 | $294.2M | $856.6M | ||
| Q1 25 | $294.8M | $859.0M | ||
| Q4 24 | $295.4M | $860.8M | ||
| Q3 24 | $296.1M | $862.7M | ||
| Q2 24 | $296.7M | $862.4M | ||
| Q1 24 | $290.8M | $866.2M |
股东权益
CERT
ECVT
| Q4 25 | $1.1B | $603.4M | ||
| Q3 25 | $1.1B | $607.9M | ||
| Q2 25 | $1.1B | $692.4M | ||
| Q1 25 | $1.1B | $698.7M | ||
| Q4 24 | $1.1B | $700.5M | ||
| Q3 24 | $1.1B | $729.4M | ||
| Q2 24 | $1.0B | $717.3M | ||
| Q1 24 | $1.1B | $711.4M |
总资产
CERT
ECVT
| Q4 25 | $1.6B | $1.3B | ||
| Q3 25 | $1.5B | $1.7B | ||
| Q2 25 | $1.5B | $1.8B | ||
| Q1 25 | $1.6B | $1.8B | ||
| Q4 24 | $1.6B | $1.8B | ||
| Q3 24 | $1.5B | $1.8B | ||
| Q2 24 | $1.5B | $1.8B | ||
| Q1 24 | $1.5B | $1.8B |
负债/权益比
CERT
ECVT
| Q4 25 | 0.28× | 0.65× | ||
| Q3 25 | 0.28× | 1.41× | ||
| Q2 25 | 0.27× | 1.24× | ||
| Q1 25 | 0.27× | 1.23× | ||
| Q4 24 | 0.28× | 1.23× | ||
| Q3 24 | 0.28× | 1.18× | ||
| Q2 24 | 0.28× | 1.20× | ||
| Q1 24 | 0.28× | 1.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $28.8M | $41.8M |
| 自由现金流经营现金流 - 资本支出 | $27.8M | $22.9M |
| 自由现金流率自由现金流/营收 | 26.8% | 11.5% |
| 资本支出强度资本支出/营收 | 1.0% | 9.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $94.4M | $69.9M |
8季度趋势,按日历期对齐
经营现金流
CERT
ECVT
| Q4 25 | $28.8M | $41.8M | ||
| Q3 25 | $32.3M | $55.3M | ||
| Q2 25 | $17.8M | $33.0M | ||
| Q1 25 | $17.4M | $10.3M | ||
| Q4 24 | $49.4M | $43.5M | ||
| Q3 24 | $17.0M | $59.9M | ||
| Q2 24 | $9.8M | $10.0M | ||
| Q1 24 | $4.3M | $36.5M |
自由现金流
CERT
ECVT
| Q4 25 | $27.8M | $22.9M | ||
| Q3 25 | $32.1M | $53.2M | ||
| Q2 25 | $17.8M | $7.8M | ||
| Q1 25 | $16.8M | $-14.0M | ||
| Q4 24 | $49.0M | $30.9M | ||
| Q3 24 | $16.8M | $53.6M | ||
| Q2 24 | $9.4M | $-9.3M | ||
| Q1 24 | $3.7M | $19.1M |
自由现金流率
CERT
ECVT
| Q4 25 | 26.8% | 11.5% | ||
| Q3 25 | 30.7% | 26.0% | ||
| Q2 25 | 17.0% | 4.4% | ||
| Q1 25 | 15.8% | -9.8% | ||
| Q4 24 | 48.8% | 20.7% | ||
| Q3 24 | 17.7% | 34.9% | ||
| Q2 24 | 10.1% | -6.1% | ||
| Q1 24 | 3.8% | 13.5% |
资本支出强度
CERT
ECVT
| Q4 25 | 1.0% | 9.4% | ||
| Q3 25 | 0.2% | 1.0% | ||
| Q2 25 | 0.1% | 14.4% | ||
| Q1 25 | 0.6% | 16.9% | ||
| Q4 24 | 0.4% | 8.5% | ||
| Q3 24 | 0.2% | 4.1% | ||
| Q2 24 | 0.5% | 12.5% | ||
| Q1 24 | 0.6% | 12.3% |
现金转化率
CERT
ECVT
| Q4 25 | — | — | ||
| Q3 25 | 21.19× | — | ||
| Q2 25 | — | 5.52× | ||
| Q1 25 | 3.66× | — | ||
| Q4 24 | 7.51× | — | ||
| Q3 24 | — | 4.21× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 29.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CERT
暂无分部数据
ECVT
| Industrial Mining Automotive | $101.3M | 51% |
| Regeneration And Treatment Services | $90.0M | 45% |
| Other | $8.1M | 4% |